Reports

Drug name	NICE TAs	Comments
Omalizumab	TA339 - Omalizumab for previously treated chronic spontaneous urticaria TA278 - Omalizumab for treating severe persistent allergic asthma	Hospital only
Omalizumab#13.5	TA339 - Omalizumab for previously treated chronic spontaneous urticaria
Omeprazole IV		Hospital use only
Ondansetron injection		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only
Ondansetron melt tablets		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only
Ondansetron SF syrup		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only
Ondansetron suppositories		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only
Ondansetron tablets		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only
Osimertinib	TA416 - Osimertinib for treating locally advanced or metastatic EGFR T790M mutation-positive non-small-cell lung cancer TA653 - Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer TA654 - Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer TA761 - Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection
Osimertinib	NICE TA Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports